In genetic testing, experience is paramount to scientific success and customer satisfaction. And for more than 25 years, Labcorp has been a pioneer in offering a true continuum of care in reproductive genetic testing and hereditary cancer testing services.
But it’s more than just providing proven-effective testing services. It’s about support, too. With the largest national commercial network of genetic counselors, nationwide access to nearly 2,000 Labcorp patient service centers, and patient-friendly tools like our online cost estimator, we offer unparalleled levels of support to you and your patients.
But it’s more than just providing proven-effective testing services. It’s about support, too. With the largest national commercial network of genetic counselors, nationwide access to nearly 2,000 Labcorp patient service centers, and patient-friendly tools like our online cost estimator, we offer unparalleled levels of support to you and your patients.
Location: United States, Massachusetts, Westborough
Employees: 501-1000
Phone: +1 800-848-4436
Founded date: 1994
Investors 1
| Date | Name | Website |
| - | Life Scien... | lspvc.com |
Mentions in press and media 17
| Date | Title | Description |
| 03.09.2014 | 800 shredded phonebooks, and shrinking next-gen data analysis sequencing times from 24 hours to 18 minutes | This could cut a company’s need for a heavy IT infrastructure, as most of the work would be done not by a network of servers or an infotech team, but a single chip. The company’s rising fast: It raised $10 million in July, with funding comi... |
| 26.03.2014 | Ariosa, maker of a genetic test for pregnant women, files for a $69M IPO | Ariosa Diagnostics is already a favorite with pregnant women. But it’s about to become a big name on Wall Street, too, with its initial public offering. Ariosa plans to offer $69 million in a proposed maximum aggregate offering price, but i... |
| 23.12.2013 | 5 memorable moments that shaped health-tech in 2013 | 2013 was a remarkable year for digital health. Health technology was one of the hottest sectors in Silicon Valley in 2013, with investors pouring $1.5 billion into the space by the end of the third quarter. Entrepreneurs jumped into health ... |
| 03.11.2013 | Genetics field opens up with California ruling that ‘natural phenomenon’ can’t be patented | In June of this year, the Supreme Court ruled that human genes should not be patented, a decision that is already having enormous impact on the future of science, technology, and medicine. This week, a District Court judge in California uph... |
| 12.10.2011 | Genetic analysis firm Sequenom selects RTP for molecular diagnostics unit | Paul Maier, president of the Sequenom Center for Molecular Medicine, said that Sequenom’s genetic analysis is more accurate than existing testing methods, less invasive and less risky. While amniocentesis provides accurate test results, its... |
| 03.06.2011 | Sequenom Receives $30M in Financing | Sequenom Inc., a San Diego biotechnology company providing genetic analysis solutions, said June 2 that it secured $30 million in financing from Silicon Valley Bank’s local office. The business said it will use the funds to support the deve... |
| 03.12.2010 | Sequenom latest genomics company to raise money | On October 27, Pacific Biosciences of California Inc. (NASDAQ:PACB) entered the market and raised $200 million. On the same day, Complete Genomics Inc. (NASDAQ:GNOM) announced that it filed for an IPO worth almost $100 million. The genome s... |
| 03.12.2010 | UPDATE: Sequenom raises $84 million in public offering | Sequenom Inc.’s (NSDQ:SQNM) $84 million public offering this week was the latest in a series of large public funding rounds for genomic analysis companies.* The San Diego-based company develops molecular diagnostics technologies for "t... |
| 11.06.2010 | Sequenom Rises as Auriga Raises to Buy, $9 Target | Shares of Sequenom (SQNM) rose 50 cents, or 8.4%, to $6.44 today after Raj Mehra of Auriga Securities raised his rating on the stock to "Buy" from "Hold," and raised his price target to $9 from $4. Mehra says he was &quo... |
| 12.05.2010 | Sequenom Gets $51.6M In PIPE | San Diego-based Sequenom, a developer of genetic analysis technology, said Wednesday that it has raised $51.6M in a private placement, from undisclosed investors. According to the firm, the new funding will go to advance research, developme... |
Show more